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Abstract
Background: This study investigates the accuracy of the reporting of medication use by proxy- and self-respondents, and it compares the 
prognostic value of the number of medications from survey and registry data for predicting mortality across self- and proxy-respondents.
Methods: The study is based on the linkage of the Longitudinal Study of Aging Danish Twins and the Danish 1905–Cohort Study with 
the Danish National Prescription Registry. We investigated the concordance between survey and registry data, and the prognostic value of 
medication use when assessed using survey and registry data, to predict mortality for self- and proxy-respondents at intake surveys.
Results: Among self-respondents, the agreement was moderate (κ  =  0.52–0.58) for most therapeutic groups, whereas among proxy-
respondents, the agreement was low to moderate (κ = 0.36–0.60). The magnitude of the relative differences was, generally, greater among 
proxies than among self-respondents. Each additional increase in the total number of medications was associated with 7%–8% mortality 
increase among self- and 4%–6% mortality increase among proxy-respondents in both the survey and registry data. The predictive value of the 
total number of medications estimated from either data source was lower among proxies (c-statistic = 0.56–0.58) than among self-respondents 
(c-statistic = 0.74).
Conclusions: The concordance between survey and registry data regarding medication use and the predictive value of the number of 
medications for mortality were lower among proxy- than among self-respondents.
Keywords: Proxy, Self-respondents, Medication use, Register study, Denmark
Most research on old-age populations is based on survey data. Typically, 
survey data are collected via interviews with selected respondents, or, 
when this is not possible, with proxy-respondents. The inclusion of 
proxy interviews overcomes some methodological problems: as it 
increases the sample size and helps researchers reach institutionalized 
populations and individuals with physical and cognitive impairments, 
it can improve the representativeness of the study population. Previous 
research has shown that the exclusion of proxy interviews leads to the 
severe underestimation of the prevalence of activities of daily living dis-
abilities, mobility limitations, and psychological problems (1). However, 
the inclusion of proxy-respondents may create another challenge, as the 
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Generally, the existing research suggests that compared to self-
respondents, proxies provide fairly accurate evaluations of physical 
functioning, frailty, and cognitive status, but less accurate assessments 
of psychological measures (2,3). Proxy-respondents are less likely 
to give accurate responses to questions on more subjective matters, 
such as emotions and pain, but they are more likely to provide accur-
ate response to questions on more easily observable indicators, such 
as measures of physical function, most chronic conditions, smoking 
history, and usual alcohol consumption and physical activity (2,4–6). 
The accuracy of reporting differs by the age of the index person, as 
proxies tend to overstate activities of daily living and instrumental 
activities of daily living disabilities for individuals aged 65-plus, and 
to understate disability levels for younger individuals (7).
Studies on medication use have generally found that the agree-
ment between self-reported data and pharmacy records varies across 
medications: that is, it is higher for medicines that are taken regu-
larly (eg, medicines for treating cardiovascular diseases, diabetes, 
and obstructive airway diseases), than for medicines that are taken 
as needed (eg, antimigraine, analgesics, hypnotics, and sedatives) 
(8–12). The lowest level of agreement is usually found for over-the-
counter medicines, for which self-reports can be a more valid source 
of data than pharmacy records (9,11). Research evidence indicates 
that the agreement between proxy and index subjects is high for 
antihypertensive medications, oral contraceptive use, and hormone 
replacement therapy and is moderate for aspirin use (6). Previous 
works, however, have been conducted in small groups of specific 
patients, and, thus, have limited generalizability to population-based 
study settings.
Medication use has been shown to be a good measure of health 
status at older ages, and it has been used as a proxy measure for 
treatment-seeking behavior (13,14). Comorbidity scores created 
using pharmacy data have been found to predict 1-year mortality 
and future physician visits among individuals aged 65-plus (13). 
As medication use is the most common form of medical treatment 
among older adult, studying patterns of medication use is essential 
for monitoring health, improving the quality of health care, and 
projecting future health care costs for old-aged populations. Our 
previous work among Danish nonagenarians has indicated that 
the number of prescription medications reported was lower among 
proxy-respondents than among self-respondents (15). In another 
study, we found that the total number of medicines reported by sur-
vey participants was lower than the total number of dispensed medi-
cations in the registry data (16). To a similar extent in both men and 
women, this gap widened as the number of prescribed medications 
increased. However, the accuracy of reporting of medication use by 
respondent type has not been analyzed.
Since surveys are the main source of information on medication 
use, and many contemporary surveys of old-aged populations allow 
for proxy-respondents, it is important to evaluate the accuracy of the 
reporting of medication use by respondent type. Thus, the present 
study aims to compare medication use reported by self-respondents 
and proxies with medication use recorded in administrative registers 
in Denmark. It also examines the prognostic value of medication use, 
when assessed using survey and registry data, for predicting mortal-
ity across self- and proxy-respondents.
Methods
Study Population
The study is based on the linkage of two surveys, the Longitudinal 
Study of Aging Danish Twins (LSADT) and the Danish 1905–Cohort 
Study (1905-Cohort), with registers maintained by the Statistics 
Denmark. The LSADT included Danish twins aged 75  years and 
older who were residing in Denmark in January 1995 (17). Follow-up 
assessments were conducted in 1997, 1999, and 2001, and included 
survivors from previous waves and newly added twins who were at 
least 70 years old at the time of the respective surveys (18).
The 1905–Cohort study included all Danes who were born in 
1905 and were alive in 1998 (aged 92–93 years), with consecutive 
waves in 2000, 2003, and 2005 involving the survivors from the 
previous waves (19). In all surveys, individuals who were residing 
in nursing homes or sheltered accommodations were considered eli-
gible to participate in the study. If individuals refused or were unable 
to participate in the face-to-face interview, a proxy-respondent—
usually a close relative—was sought. The two studies are compar-
able with regard to their design, implementation, and data collection 
instruments; with only minor differences that are mainly related to 
the age distributions in the two surveys.
The Danish Civil Registration System (CRS) contains individual-
level sociodemographic information on all residents of the country 
(20). Using a unique 10-digit Civil Personal Register (CPR) num-
ber, it is possible to link various thematically organized registers at 
the individual level. All LSADT and 1905-Cohort participants were 
linked to the Danish National Prescription Registry (DNPR), which 
contains the Anatomical Therapeutic Chemical (ATC) classification 
system codes of all dispensed medications, dates of purchase, and 
other drug-related information since 1995 (21).
Medication Use
The reported information on medication use in the LSADT and the 
Danish 1905-Cohort study was obtained by asking the participants/
proxy-respondents to list all medicines they take on a regular basis. 
To avoid recall bias, respondents were asked to present their drug 
storage or medication list. All prescribed medications reported by 
the participants were assigned an ATC code by a pharmacologist 
(22). Alternative medications and vitamins were excluded. Because 
the DNPR codes are available since 1995, the analyses of medica-
tion use in the LSADT data include the intake participants in 1997, 
1999, and 2001.
Medication use in the registry data is assessed using a 4-month 
fixed-time window (8), because in Denmark patients receive a 
3-month reserve of each medication, and another 30 days are added 
to account for minor noncompliance and irregular filling patterns 
(23). As the drugs administered in hospitals are reported on the ward 
level, they are not included in the present analysis.
Statistical Analysis
Kappa statistics were estimated for self- and proxy-respondents sep-
arately to assess the agreement in medication use information in the 
survey and registry data at the ATC therapeutic subgroup level (ATC 
level 2). The most commonly used therapeutic groups were selected: 
A02—medicines for acid-related disorders, B01—antithrombotic 
agents, C01—cardiac therapy, C03—diuretics, N02—analgesics, 
N05—psycholeptics, and R03—medicines for obstructive air-
way disease. Psychotropic medications were selected to determine 
whether there was lower agreement due to the reluctance of survey 
participants to report these medications to the interviewers.
We compared the total numbers of reported and registered medi-
cations for each study participant. The number of medications for 
each individual in the data was estimated as a total count of unique 
medications at the chemical subgroup level (ATC level 4). To reveal 
potential systematic differences between the two data sources, the 
relative difference was calculated as the difference between the mean 
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number of medications in the survey and registry data as a percent-
age of the mean number of medications in the registry. The agree-
ment between the survey and registry data was assessed for total 
drug use and for the most commonly used medicines at the ATC 
1 level: cardiovascular (ATC-C), alimentary tract and metabolism l 
(ATC-A), blood and blood-forming organs (ATC-B), nervous (ATC-
N), and respiratory (ATC-R) system medications. For each index 
person, the relative differences in total drug use were calculated by 
gender and 10-year age group. A similar analysis for system-specific 
medications by gender and age group was not feasible due to the 
small number of study participants in each group.
Cox proportional hazard regression models were used to exam-
ine the association between the numbers of medications from the 
survey and registry data and mortality for the self- and proxy-
respondents. In all of the models, we defined the time scale as sur-
vival from the date of the interview to the date of death or the end 
of the follow-up, whichever came first. Adjustments were made for 
each index person’s age, gender, education (<7 years, 7–8, 9–10, 11+, 
other), marital status (married, never married, divorced, widowed, 
unknown), and total number of hospitalizations in the three years 
prior to the interview (none, 1, 2, 3+). To account for within-twin-
pair similarities, robust standard errors were estimated that allow 
for clustering within each twin pair, and that assume the independ-
ence of each pair (24). The proportional hazards assumption for 
each covariate was tested on the basis of Schoenfeld residuals after 
fitting a model. No crude violations of proportional hazards assump-
tion were detected. All of the analyses were performed using STATA, 
version 14.0. Also, we estimated c-statistic (c) to compare the model 
performance in predicting mortality for self- and proxy-respondents 
and from survey and registry data (25). As the estimation procedure 
for c-statistic assumes that the individuals in the sample are inde-
pendent and life spans of twins are known to be correlated (26), we 
dropped randomly one of the twins in a pair, if both twins partici-
pated in the LSADT. C-statistic was estimated in R, version 3.3.2, 
library survAUC.
Results
The prevalence of different ATC medication groups in the survey 
and registry data and the kappa with 95% confidence intervals 
(CIs) for the self- (n = 4,098) and proxy-respondents (n = 492) at all 
baseline waves are presented in Table 1. Among the self- and proxy-
respondents, the survey and registry data on medication use showed 
that diuretics and analgesics were the most frequently used, while 
medicines for obstructive airway disease were the least frequently 
used. When registry data were considered, the prevalence of all 
medications, with the exception of medicines for obstructive airway 
disease, was consistently lower among self-respondents than among 
proxies; whereas there was no such clear pattern in the survey data.
Among self-respondents, the agreement was moderate (κ = 0.52–
0.58) for most therapeutic groups: antithrombotic agents, analge-
sics, medicines for acid-related disorder, and psycholeptics (Table 1). 
High agreement was found for cardiac therapy (0.85, 95% CI: 
0.82, 0.88) and diuretics (0.78, 95% CI: 0.75, 0.81). Among proxy-
respondents, the agreement was low to moderate for all therapeutic 
groups (κ = 0.36–0.60) and was lower than among self-respondents, 
with the exception of medicines for obstructive airway disease (0.83, 
95% CI: 0.75, 0.92).
Figure  1 shows that for more than half of self- and proxy-
respondents, the absolute difference in the total numbers of medica-
tions between the two data sources varied between −1 and 1. The 
distribution was left-skewed, and the skewness was stronger among 
proxy-respondents than among self-respondents.
To examine potential systematic differences between the two 
data sources, we calculated the relative differences between the total 
number of reported medications and the total number of registered 
medications for all-cause and system-specific medications. A nega-
tive relative difference indicated that the number of medications 
was smaller in the survey data than in the registry data. Figure 2 
shows that for both proxy- and self-respondents, the relative differ-
ences were negative for all-cause medications and for cardiovascular 
(ATC-C), nervous (ATC-N), and respiratory (ATC-R) system medi-
cations. The relative differences were greater among proxies than 
among self-respondents for these medicine groups; except for the 
ATC-R medications, for which the relative differences were similar. 
In contrast, the relative differences were positive for alimentary tract 
and metabolism medicines (ATC-A), and were almost zero for blood 
and blood-forming medicines (ATC-B) among self-respondents. 
Among proxy-respondents, the relative differences were negative for 
both medicine groups.
Finally, we assessed whether the prognostic value of medication 
use for predicting mortality varied between self- and proxy-respond-
ents and between the two data sources. Among self-respondents, 
each additional medication was associated with a 7% (hazard ratio 
[HR] = 1.07, 95% CI: 1.06, 1.08) and an 8% (HR = 1.08, 95% 
CI: 1.06, 1.09) increase in mortality in the registry and survey data, 
Table 1. Prevalence of Medication Use in and the Agreement Between the Survey and Registry Data by Response Type
Self-respondents (n = 4,098) Proxy-respondents (n = 492)
Prevalence Prevalence
Medication Survey Registry κ 95% CIa Survey Registry κ 95% CI
A02b 13.1 12.7 0.55 0.52 0.58 16.5 16.5 0.36 0.28 0.45
B01 20.9 21.8 0.52 0.49 0.55 11.8 24.6 0.41 0.33 0.49
C01 15.1 16.2 0.85 0.82 0.88 14.8 22.0 0.60 0.52 0.69
C03 33.1 33.9 0.78 0.75 0.81 28.7 47.8 0.43 0.35 0.51
N02 26.2 22.3 0.53 0.50 0.56 33.9 47.6 0.45 0.37 0.54
N05 16.6 27.9 0.58 0.55 0.61 20.3 44.1 0.42 0.34 0.49
R03 6.7 8.2 0.81 0.78 0.84 3.0 3.3 0.83 0.75 0.92
Note: aCI = Confidence interval. b: A02—medicines for acid-related disorders, B01—antithrombotic agents, C01—cardiac therapy, C03—diuretics, N02—anal-
gesics, N05—psycholeptics, and R03—medicines for obstructive airway disease.







edgerontology/article/74/5/742/5040076 by guest on 25 August 2021
respectively, in the model adjusted for the total number of hospi-
talizations (Figure  3 and Supplementary Table  2). Among proxy-
respondents, the levels of association between the total number 
of medications and mortality were lower for both the survey data 
(HR = 1.05, 95% CI: 1.02, 1.09) and the registry data (HR = 1.03, 
95% CI: 1.00, 1.06) in the model adjusted for all selected covariates 
than among self-respondents (Figure 3 and Supplementary Table 2).
In the subsamples with no restriction of follow-up times, the 
number of medications performed similarly in predicting mortality 
among self- versus proxy-respondents and in registry versus survey 
data varying from 0.53 to 0.58 (c-100% in Supplementary Table 3). 
However, in the subsamples, where 10% of the individuals with the 
longest follow-up times were censored, the predictive ability of the 
number of medications for mortality remained unchanged among 
proxy respondents in survey and registry data: 0.58 and 0.56, 
respectively, while it improved among self-respondents: 0.74 in both 
survey and registry data (c-90% in Supplementary Table 3). These 
results suggest that the performance of the number of medications in 
predicting mortality is greater among self-respondents than among 
proxy-respondents.
Discussion
The present study, which utilized data from large-scale longitudinal 
studies previously conducted in Denmark, has demonstrated that 
the concordance between survey and registry data with respect to 
medication use differed among self- and proxy-respondents. For 
most therapeutic groups, the agreement between survey and registry 
data was lower among proxies than among self-respondents, vary-
ing from moderate to high among self-respondents, and from low 
to moderate among proxy-respondents. In addition, the magnitude 
of the relative differences in the total numbers of medications in the 
survey and registry data was larger for proxies than for self-respond-
ents for all but respiratory system medicines. The total numbers of 
reported medications were lower in the survey than in the registry 
data for all-cause and most system-specific medications among self- 
and proxy-respondents. Finally, we also found that the prognostic 
value of the total number of medications estimated from either 
data source was lower among proxies than among self-respondents. 
However, among both self-respondents and proxies, the prognostic 
value for mortality of the total number of medications was similar 
when assessed using survey versus registry data.
In line with other studies (8,9,11), we found that the agreement 
was higher for medicines that are taken regularly, such as cardio-
vascular system medications, than for medicines that are taken as 
needed. Our findings of high concordance between survey and regis-
try data on medicines for obstructive airway disease among self- and 
proxy-respondents are not surprising because 78% of these medi-
cines are inhalants, the use of which can be easily observed by fam-
ily members/caregivers. Research evidence has shown that proxies 
are more likely to provide accurate responses to questions regarding 
more easily observable indicators than to questions of a more sub-
jective nature (4,5). High agreement—albeit lower than in the pre-
sent study—was found for obstructive airway disease medicines in 
previous studies that compared medication use based on self-reports 
and pharmacy records (8,9).
The present study utilized data from the DNPR, which enabled 
us to examine medication use at the individual level in a whole study 
population. The negative relative differences we found between the 
total numbers of reported and registered medications may point 
to the under-reporting of medication use among all respondents. 
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Figure  2. Relative differences in the total numbers of medications in the 
survey and registry data by response type.
Figure 3. Hazard ratios for mortality for the total number of medications by 
response type and data source. CI = Confidence interval.
Figure  1. Distribution of the absolute differences in the total numbers of 
medications in the survey and registry data by response type.
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dispensed medications, they may not reflect individuals’ actual medi-
cine use. In the present study, we were unable to assess whether the 
negative relative differences observed between the total numbers of 
reported and registered medications were due to the under-reporting 
of medication use by survey participants or to non-adherence to pre-
scribed medical treatment. Although survey participants were asked 
to consult their drug storage or medication list to avoid recall bias, 
they might have forgotten about some of the medications in their 
drug storage, especially those that are not used regularly.
Previous research showed that characteristics of the proxy-
respondents may influence the accuracy of the health assessment of 
the index subjects (6,27). Among all proxy-respondents, the most 
reliable responses on alcohol consumption and antihypertensive 
medication use were provided by wives, and that the most reliable 
responses on contraceptive use were provided by husbands but that 
the proximity of the proxy to the index subject had little influence 
on the reliability of responses on smoking status (6). Although the 
data collection instrument used in the Danish surveys included items 
on the relationships of proxy-respondents to the index persons and 
the frequency of the contact, it was not possible to investigate how 
these characteristics influenced the concordance between survey and 
registry data due to the small numbers in each proxy group. Another 
limitation of the present study is that because we utilized data con-
ducted within approximately the same time period and in a single 
country, our findings may not be representative for other settings.
In conclusion, our analyses have shown that the concordance be-
tween survey and registry data regarding medication use differed 
between self- and proxy-respondents. We also have found that the pre-
dictive value of the number of medications for mortality is lower among 
proxy- than among self-respondents. These findings suggests that the 
levels of medication use and its ability to predict mortality may be 
underestimated when assessed through surveys, when proxy-respond-
ents are involved. Thus, when studying medication use, it is desirable to 
supplement survey data with pharmacy records, if available.
Supplementary Material
Supplementary data is available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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